Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
02/2012
02/16/2012US20120039944 Whey and thymus function
02/16/2012US20120039943 Factors
02/16/2012US20120039942 Outer membrane vesicles and uses thereof
02/16/2012US20120039941 Engineered botulinum neurotoxin
02/16/2012US20120039939 Compositions and methods for vaccine and virus production
02/16/2012US20120039937 Induction of an immune response against dengue virus using the prime-boost approach
02/16/2012US20120039936 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
02/16/2012US20120039934 Adjuvant-sparing multi-dose influenza vaccination regimen
02/16/2012US20120039933 Methods for one-dose intradermal delivery for non-live trivalent influenza vaccine
02/16/2012US20120039932 Lentiviral Vectors Pseudotyped with a Sindbis Virus Envelope Glycoprotein
02/16/2012US20120039926 Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells
02/16/2012US20120039925 Tuberculosis tb vaccine to prevent reactivation
02/16/2012US20120039924 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
02/16/2012US20120039922 Method and peptide for regulating cellular activity
02/16/2012US20120039921 Poultry viral materials and methods related thereto
02/16/2012US20120039920 Hydrophobic monomers, hydrophobically-derivatized supports, and methods of making and using the same
02/16/2012US20120039919 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods
02/16/2012US20120039918 Composition for Enhancing Immunity Containing Plant Stem Cell Line Derived from Cambium of Panax Ginseng Including Wild Ginseng or Ginseng as an Active Ingredient
02/16/2012US20120039917 Immunomodulating activities
02/16/2012US20120039916 Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
02/16/2012US20120039911 Cd93 or use of soluble fragment thereof
02/16/2012US20120039910 Novel Use of IL-1beta Compounds
02/16/2012US20120039908 Control of Protein Glycosylation and Compositions and Methods Relating Thereto
02/16/2012US20120039906 PD-1 Antibodies and PD-L1 Antibodies and Uses Thereof
02/16/2012US20120039903 Methods for suppressing an immune response or treating a proliferative disorder
02/16/2012US20120039902 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
02/16/2012US20120039900 Biomarkers predictive of the responsiveness to tnfalpha inhibitors in autoimmune disorders
02/16/2012US20120039899 Anti-Hemagglutinin Antibody Compositions And Methods Of Use Thereof
02/16/2012US20120039890 Methods of treatment using antibodies to neutrokine-alpha
02/16/2012US20120039884 Compositions and methods for treating cardiovascular disease
02/16/2012US20120039883 Detection and diagnosis of inflammatory disorders
02/16/2012US20120039874 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
02/16/2012US20120039871 Methods and compositions for antibody therapy
02/16/2012US20120039870 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof
02/16/2012US20120039869 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
02/16/2012US20120039868 Biomarkers for Graft Rejection
02/16/2012US20120039867 Immune System Function in Conditions Characterized by Elevated Double Strand Breaks
02/16/2012US20120039849 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
02/16/2012US20120039844 Composition and use of n-alpha-methylhistamine dihydrochloride for the reduction of oxygen radical formation
02/16/2012US20120039842 Compositions and methods that enhance an immune response
02/16/2012US20120039841 T-Helper Cell Type 17 Lineage-Specific Adjuvants, Compositions and Methods
02/16/2012US20120039840 Use of IL-27-P28 to antagonize IL-6 mediated signaling
02/16/2012US20120039806 Compounds and Methods for Modulating an Immune Response
02/16/2012US20120039797 Antibody Therapy
02/16/2012US20120039796 Novel method for creating, suspending and stabilizing electronically modified oxygen derivatives, along with creating, suspending and stabilizing electronically modified reaction intermediates, in a bio compatible fluorocarbon suspension, for the purpose of inducing a cascading immune response in mammalian patients
02/16/2012CA2843684A1 Compositions, kits and methods for treatment of complement-related disorders
02/16/2012CA2808435A1 Heterocyclic compound
02/16/2012CA2807051A1 Besylate salt of a btk inhibitor
02/15/2012EP2418224A2 Reducing the risk of human and anti-human antibodies through V gene manipulation
02/15/2012EP2418207A1 Sulfone compounds which modulate the CB2 receptor
02/15/2012EP2418206A2 Benzodiazepine derivatives useful in the treatment of autoimmune disorders
02/15/2012EP2418196A1 Dual alanyl-aminopeptidase and dipeptidyl-peptidase IV inhibitors
02/15/2012EP2417974A1 Combination therapy for treatment of immune disorders
02/15/2012EP2417165A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
02/15/2012EP2417130A2 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
02/15/2012EP2417120A1 Substituted piperidines as ccr3 antagonists
02/15/2012EP2416802A1 Method for treating immune disorders
02/15/2012EP2416801A1 Immunogenic composition and uses thereof
02/15/2012EP2416791A1 Myeloid-derived suppressor cells generated in vitro
02/15/2012EP1957083B1 Beta glycolipids as immuno-modulators
02/15/2012EP1381432B1 HSA-free formulations of interferon-beta
02/15/2012EP1071457B1 Polymer particle vaccine delivery system
02/15/2012CN1536069B 大规模生产虫草菌和灵芝菌的方法 Mass production of Cordyceps and Ganoderma lucidum methods
02/15/2012CN102356152A Process for producing lactic acid bacterium having enhanced immunomodulating activity
02/15/2012CN102355908A Nanoparticle formulated glycolipid antigens for immunotherapy
02/15/2012CN102355902A Treatment of neurotrophic factor mediated disorders
02/15/2012CN102351959A Preparation method and application of multiflower knotweed vine polysaccharide chelate zinc
02/15/2012CN102351958A Preparation method and application of astragalus polysaccharide-calcium complex
02/15/2012CN102350000A Application of heterogeneous bluetongue virus dsRNA (double-strand ribonucleic acid) in preparation of endogenic interferon inducer
02/15/2012CN102349993A Bupleurum tenue granules and preparation method thereof
02/15/2012CN102349975A Health care product formula of dendrobium officinale, composition as well as preparation method and application of composition
02/15/2012CN102349934A Extraction process of effective ingredients from cordyceps mycelia
02/15/2012CN102349865A Green bean sprout extract and preparation method and use thereof
02/15/2012CN102078366B 一种三叶青消炎抗病毒含片的制作方法 Yeh method of making a three-inflammatory tablets of anti-viral
02/15/2012CN101904953B 一种抗炎镇痛药物组合物及其制备方法和用途 An anti-inflammatory analgesic composition and preparation method and uses
02/15/2012CN101747259B 氮杂糖类化合物及其合成方法及应用 Aza carbohydrates and synthesis method and its application
02/15/2012CN101732356B 一种治疗颈肩腰腿痛的提脓拔毒膏 A treatment for neck and back pain mention pus Sida cream
02/15/2012CN101721458B 一种人胎盘组织液的制备方法 A human placental tissue fluid preparation
02/15/2012CN101530389B 人参皂苷Rg3磷脂复合物及其制备方法 Ginsenoside Rg3 phospholipid complex and its preparation method
02/15/2012CN101460620B 免疫刺激寡核苷酸及其药物用途 Immunostimulatory oligonucleotides and pharmaceutical use
02/15/2012CN101218340B 双歧杆菌属的微生物生产的多糖 Polysaccharides produced by microorganisms of the genus Bifidobacterium
02/15/2012CN101172099B 稳定等渗的冻干蛋白质制剂 Stable lyophilized protein formulations isotonic
02/14/2012US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/14/2012US8114965 Compositions of PSMA antibodies
02/14/2012US8114878 PDE4 (Phosphodiesterase) inhibitors; respiratory diseases, gastrointestinal diseases, inflammation the joints, skin or eyes, cancers, or diseases of the peripheral or central nervous system
02/14/2012US8114840 Medicament containing activated antithrombin III
02/14/2012US8114618 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
02/14/2012US8114603 collecting a blood sample from the subject; andmeasuring the levels of Triggering Receptor Expressed on Myeloid cells (TREM-1) splice variant protein in sample, a decrease in the levels of TREM-1 splice variant indicates an inflammatory response
02/14/2012US8114442 Transdermal pharmaceutical delivery compositions
02/14/2012US8114418 Chimeric immunomodulatory compounds and methods of using the same—IV
02/09/2012WO2012018790A2 Dual variable domain immunoglobulins and uses thereof
02/09/2012WO2012017678A1 Immunological function enhancing agent
02/09/2012WO2012017408A1 Preparation of conjugates comprising adenine derivatives and allergenic proteins and their use for specific immunotherapy of allergenic diseases
02/09/2012WO2012017093A1 Bacterial ghosts for mediating innate immunity
02/09/2012WO2012016328A1 Portable soft gel droplet delivery device for treating poultry
02/09/2012US20120035529 Tumor vascular marker-targeted vaccines
02/09/2012US20120035268 Sphingo-guanidines and their use as inhibitors of sphingosine kinase
02/09/2012US20120035251 Thiophene inhibitors of ikk-b serine-threonine protein kinase
02/09/2012US20120035245 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
02/09/2012US20120035239 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 1172